EIF5A2 and hepatocellular carcinoma: According to the K-M survival analysis, the OS and RFS of HCC patients with highly expressed EIF5A2 in the TCGA-LIHC database were lower than those of those with lowly expressed EIF5A2 (Figure 5B,C).